Stapled Intracellular-Targeting Antimicrobial Peptides to Treat Infection
Copyright © Targeted News Service 2024
2024-04-02
ALEXANDRIA, Virginia, April 2 -- DANA-FARBER CANCER INSTITUTE, INC., Boston, Massachusetts has been assigned a patent (No. US 11945846 B2, initially filed March 9, 2020) developed by Loren D. Walensky, Newton, Massachusetts, and Rida Mourtada, Brookline, Massachusetts, for "Stapled intracellular-targeting antimicrobial peptides to treat infection." . . .